Surgery Partners Stock Analysis
| SGRY Stock | USD 24.21 0.18 0.74% |
Surgery Partners is undervalued with Real Value of 30.61 and Target Price of 33.52. The main objective of Surgery Partners stock analysis is to determine its intrinsic value, which is an estimate of what Surgery Partners is worth, separate from its market price. There are two main types of Surgery Partners' stock analysis: fundamental analysis and technical analysis.
The Surgery Partners stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Surgery Partners is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Surgery Stock trading window is adjusted to America/New York timezone.
Surgery |
Surgery Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 1.33. The firm had not issued any dividends in recent years. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people. To find out more about Surgery Partners contact the company at 615 234 5900 or learn more at https://www.surgerypartners.com.Surgery Partners Quarterly Total Revenue |
|
Surgery Partners Investment Alerts
| Surgery Partners had very high historical volatility over the last 90 days | |
| Surgery Partners has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Disposition of 3156 shares by Marissa Brittenham of Surgery Partners at 24.09 subject to Rule 16b-3 |
Surgery Partners Upcoming and Recent Events
Earnings reports are used by Surgery Partners to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Surgery Largest EPS Surprises
Earnings surprises can significantly impact Surgery Partners' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-05-05 | 2016-03-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2022-08-02 | 2022-06-30 | -0.01 | -0.03 | -0.02 | 200 | ||
2020-03-05 | 2019-12-31 | 0.12 | 0.1 | -0.02 | 16 |
Surgery Partners Environmental, Social, and Governance (ESG) Scores
Surgery Partners' ESG score is a quantitative measure that evaluates Surgery Partners' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Surgery Partners' operations that may have significant financial implications and affect Surgery Partners' stock price as well as guide investors towards more socially responsible investments.
Surgery Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.9 M | Point72 Asset Management, L.p. | 2024-12-31 | 1.7 M | American Century Companies Inc | 2024-12-31 | 1.4 M | Goldman Sachs Group Inc | 2024-12-31 | 1.3 M | E Ohman J:or Asset Management Ab | 2024-12-31 | 1.2 M | Victory Capital Management Inc. | 2024-12-31 | 1.2 M | Hein Park Capital Management Lp | 2024-12-31 | 1.1 M | Silvercrest Asset Management Group Llc | 2024-12-31 | 998.5 K | Ubs Group Ag | 2024-12-31 | 990.2 K | Bain Capital Investors Llc | 2024-12-31 | 49.9 M | Fmr Inc | 2024-12-31 | 16.3 M |
Surgery Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.09 B.Surgery Profitablity
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.05 | 0.06 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.09) | (0.09) |
Management Efficiency
Surgery Partners has return on total asset (ROA) of 0.0401 % which means that it generated a profit of $0.0401 on every $100 spent on assets. This is way below average. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.06 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.06). At this time, Surgery Partners' Intangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.76 in 2025, whereas Total Assets are likely to drop slightly above 5 B in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 28.82 | 30.26 | |
| Tangible Book Value Per Share | (11.72) | (12.31) | |
| Enterprise Value Over EBITDA | 5.57 | 5.29 | |
| Price Book Value Ratio | 1.49 | 1.57 | |
| Enterprise Value Multiple | 5.57 | 5.29 | |
| Price Fair Value | 1.49 | 1.57 | |
| Enterprise Value | 2.5 B | 1.9 B |
The strategic initiatives led by Surgery Partners' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 23rd of March, Surgery Partners has the Risk Adjusted Performance of 0.0897, coefficient of variation of 1076.87, and Semi Deviation of 1.66. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them.Surgery Partners Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Surgery Partners middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Surgery Partners. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Surgery Partners Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgery Partners insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgery Partners Outstanding Bonds
Surgery Partners issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgery Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgery bonds can be classified according to their maturity, which is the date when Surgery Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Surgery Partners Predictive Daily Indicators
Surgery Partners intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgery Partners stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Surgery Partners Corporate Filings
F4 | 17th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 13th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 7th of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 6th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 4th of March 2025 Other Reports | ViewVerify | |
8K | 3rd of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of February 2025 Other Reports | ViewVerify | |
| 10th of February 2025 Other Reports | ViewVerify |
Surgery Partners Forecast Models
Surgery Partners' time-series forecasting models are one of many Surgery Partners' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgery Partners' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Surgery Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgery Partners prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgery shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgery Partners. By using and applying Surgery Stock analysis, traders can create a robust methodology for identifying Surgery entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.05 | 0.03 | |
| Operating Profit Margin | 0.11 | 0.15 | |
| Net Loss | (0.05) | (0.05) | |
| Gross Profit Margin | 0.24 | 0.31 |
Current Surgery Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgery analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgery analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 33.52 | Strong Buy | 13 | Odds |
Most Surgery analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgery stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgery Partners, talking to its executives and customers, or listening to Surgery conference calls.
Surgery Stock Analysis Indicators
Surgery Partners stock analysis indicators help investors evaluate how Surgery Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgery Partners shares will generate the highest return on investment. By understating and applying Surgery Partners stock analysis, traders can identify Surgery Partners position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 195.9 M | |
| Long Term Debt | 3.3 B | |
| Common Stock Shares Outstanding | 126.1 M | |
| Total Stockholder Equity | 1.8 B | |
| Tax Provision | 134.6 M | |
| Property Plant And Equipment Net | 1.4 B | |
| Cash And Short Term Investments | 269.5 M | |
| Cash | 269.5 M | |
| Accounts Payable | 208.7 M | |
| Net Debt | 124 M | |
| 50 Day M A | 23.8448 | |
| Total Current Liabilities | 624.4 M | |
| Other Operating Expenses | 2.9 B | |
| Non Current Assets Total | 6.8 B | |
| Forward Price Earnings | 28.8184 | |
| Non Currrent Assets Other | 57.5 M | |
| Stock Based Compensation | 33.3 M |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.